Caudal Versus Intravenous Dexmedetomidine for Supplementation of Caudal Analgesia in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Inguinal HerniaCryptorchidism
Interventions
DRUG

Caudal Dexmedetomidine

"Caudal: Levobupivacaine 0.25% 1ml/kg and dexmedetomidine 1µg/kg~Intravenous: 10 ml normal saline"

DRUG

Intravenous Dexmedetomidine

"Caudal: Levobupivacaine 0.25% 1ml/kg~Intravenous: dexmedetomidine 1µg/kg"

DRUG

Placebo

"Caudal: Levobupivacaine 0.25% 1ml/kg~Intravenous: 10 ml normal saline"

DRUG

sevoflurane

Induction and maintain anaesthesia

Trial Locations (1)

350001

Fujian Provincial Hospital, Fuzhou

All Listed Sponsors
collaborator

West China Hospital

OTHER

lead

Yao Yusheng

OTHER

NCT01701778 - Caudal Versus Intravenous Dexmedetomidine for Supplementation of Caudal Analgesia in Children | Biotech Hunter | Biotech Hunter